PLEASANTON, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in products to treat cardiovascular disease, today announced that it will report its operating results for fiscal 2006 on Thursday, February 15.
The company will hold a conference call to discuss its financial results and operating activities to all interested parties at 8:30 a.m., Pacific Standard Time (11:30 p.m. Eastern Standard Time) Thursday, February 15, hosted by Gary F. Burbach, president and chief executive officer, and David Smith, executive vice president and chief financial officer.
The teleconference can be accessed by calling (913) 981-5567, passcode 6615704. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available the Internet at http://phx.corporate- ir.net/phoenix.zhtml?p=irol-eventDetails&c=95989&eventID=1458998 or at http://www.thoratec.com.
A replay of the conference call will be available through Thursday, February 22, via http://www.thoratec.com or by telephone at (719) 457-0820, passcode 6615704.
Thoratec Corporation is a world leader in therapies to address advanced stage heart failure. The company’s product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company’s web sites at http://www.thoratec.com or http://www.itcmed.com
TNR-432
Thoratec Corporation
CONTACT: David Smith of Executive Vice President, Chief Financial Officerof Thoratec Corporation, +1-925-847-8600; or Neal Rosen of Kalt Rosen &Co., +1-415-397-2686
Web site: http://www.thoratec.com//
